Medicinal Plants as Therapeutic Alternatives to Combat Mycobacterium tuberculosis: A Comprehensive Review
Authors:
- Silvi GautamSGSilvi Gautam
- Kamal A. QureshiKamal A. Qureshi
- Shabaaz Begum Jameel PashaSPShabaaz Begum Jameel Pasha
- Sugapriya DhanasekaranSDSugapriya Dhanasekaran
- Ashok AspatwarAshok Aspatwar
- Seppo ParkkilaSPSeppo Parkkila
- Samyah AlanaziSASamyah Alanazi
- Akhtar AtiyaAAAkhtar Atiya
- Mohd Masih Uzzaman KhanMohd Masih Uzzaman Khan
- Divya VenugopalDVDivya Venugopal
Open Access
- 8 March 2023
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 12 (3) , 541
Abstract
Tuberculosis (TB) is a serious infectious disease caused by Mycobacterium tuberculosis (MTB) and a significant health concern worldwide. The main threat to the elimination of TB is the development of resistance by MTB to the currently used antibiotics and more extended treatment methods, which is a massive burden on the health care system. As a result, there is an urgent need to identify new, effective therapeutic strategies with fewer adverse effects. The traditional medicines found in South Asia and Africa have a reservoir of medicinal plants and plant-based compounds that are considered another reliable option for human beings to treat various diseases. Abundant research is available for the biotherapeutic potential of naturally occurring compounds in various diseases but has been lagging in the area of TB. Plant-based compounds, or phytoproducts, are being investigated as potential anti-mycobacterial agents by reducing bacterial burden or modulating the immune system, thereby minimizing adverse effects. The efficacy of these phytochemicals has been evaluated through drug delivery using nanoformulations. This review aims to emphasize the value of anti-TB compounds derived from plants and provide a summary of current research on phytochemicals with potential anti-mycobacterial activity against MTB. This article aims to inform readers about the numerous potential herbal treatment options available for combatting TB.Keywords
Funding Information
- King Khalid University (RGP.2/137/1443)
- The Finnish Cultural Foundation (RGP.2/137/1443)
- The Tampere Tuberculosis Foundation (RGP.2/137/1443)
- the Jane and Aatos Erkko Foundation (RGP.2/137/1443)
- the Finnish Foundation for Cardiovascular Research (RGP.2/137/1443)
- The Academy of Finland, Finland (RGP.2/137/1443)
This publication has 101 references indexed in Scilit:
- Anti-protozoal activity of aporphine and protoberberine alkaloids from Annickia kummeriae (Engl. & Diels) Setten & Maas (Annonaceae)BMC Complementary and Alternative Medicine, 2013
- Antitubercular Activity and the Subacute Toxicity of (−)-Licarin A in BALB/c Mice: A Neolignan Isolated from Aristolochia taliscanaArchives of Medical Research, 2013
- Corticosteroid Use for Paradoxical Reactions during Antibiotic Treatment for Mycobacterium ulceransPLOS Neglected Tropical Diseases, 2012
- Antimycobacterial Activity of Constituents from Foeniculum vulgare Var. Dulce Grown in MexicoMolecules, 2012
- Dihydro-β-agarofuran sesquiterpenes isolated from Celastrus vulcanicola as potential anti-Mycobacterium tuberculosis multidrug-resistant agentsBioorganic & Medicinal Chemistry, 2011
- Flourensia cernua: Hexane Extracts a Very Active Mycobactericidal Fraction from an Inactive Leaf Decoction against Pansensitive and Panresistant Mycobacterium tuberculosisEvidence-Based Complementary and Alternative Medicine, 2011
- Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activityEuropean Journal of Medicinal Chemistry, 2010
- Antifungal, antibacterial and antimycobacterial activity of Entada abysinnica Steudel ex A. Rich (Fabaceae) methanol extractPharmacognosy Research, 2010
- Antimicrobial and Antioxidant Activities of Coumarins from the Roots of Ferulago campestris (Apiaceae)Molecules, 2009
- Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animalsNutrition & Metabolism, 2008